NCT04256135

Brief Summary

Introduction: Knee osteoarthritis is a clinical syndrome which is characterized by pain. It has been shown to cause changes in the nervous system leading to central sensitization. There are factors involved in this disease such as sex (female) or obesity. The most recommended therapy is physical therapy, but manual therapy is needed to cause changes in central sensitization. Methods: Experimental, prospective, parallel and longitudinal double-blind study, in which two groups are performed: group A (AP mobilizations) and group B (Mulligan's mobilizations). Different variables and questionnaires were used: pressure pain threshold, temporal summation, pain modulation, central sensitization inventory, WOMAC, Times Up \& GO, numerical rating scale, Beck, STAI, kinesiophobia, catastrophism, Barthel and mini- cognitive test

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

April 30, 2020

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2020

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2020

Completed
Last Updated

July 27, 2020

Status Verified

July 1, 2020

Enrollment Period

15 days

First QC Date

February 3, 2020

Last Update Submit

July 23, 2020

Conditions

Keywords

Mulligan mobilizationMaitland mobilizationManual therapy

Outcome Measures

Primary Outcomes (3)

  • Changes in Mechanical Hyperalgesia

    To measure the pain thresholds by pressure we use an algometer with a surface area of 1cm2 applying it perpendicularly to the skin with a speed of 1 kg / cm2 / s until the patient indicates that the first sensation of pain appears, ceasing at that moment the pressure made. Three measurements will be recorded with an interval of 30 seconds to avoid a temporal sum effect. The measurement will be taken in a distal region of the ipsilateral carpal long radial extender (a point distal to the carpal long radial extender (5cm distal to the lateral epicondyle)) and in the peripatellar region the standard UDP assessment protocol will be used. In the patellar region two sites will be evaluated (3cm medial and lateral to the midpoint of the lateral and medial patella border). A minimum change of 1.62-1.53 kg / cm2 is required for the result to be clinically significant.

    Change from Baseline Mechanical Hyperalgesia at 4th sessions

  • Changes in Temporal Summation

    First the pressure pain thresholds are measured in the lateral area to the patella. Then 10 consecutive pulses are performed in the same locations to provoke the temporal sum, increasing the pressure by 2kg/s and maintaining it for 1 second (followed by 1 second of rest) in each pulse. The intensity of the pain is evaluated at the 1st, 5th and 10th pulse, by means of a numerical scale of the pain (0 being painless and 10 being the maximum pain imaginable).

    Change from Baseline Mechanical Hyperalgesia at 4th sessions

  • Changes in Conditioned pain modulation

    First, pressure pain stimulus (test stimulus) will be conducted in the lateral area to the patella. Second, occlusion cuff will be inflated around the arm of patient until the patient feeling a painful intensity (conditioned stimulus) of 6/10. Finally, after 30 seconds the stimulus will be done. The difference in the mean value of the initial algometry with the mean value of algometry during the conditioning stimulus will indicate the state of the descending pain inhibitory system.

    Change from Baseline Mechanical Hyperalgesia at 4th sessions

Secondary Outcomes (10)

  • Central sensitization inventory

    Baseline

  • WOMAC Questionnaire

    Baseline

  • Test Time Up & Go

    Change from Baseline Mechanical Hyperalgesia at 1 month

  • Numerical rating scale (NRS)

    Change from Baseline Mechanical Hyperalgesia at 4th sessions

  • Beck Depression Inventory (BDI)

    Baseline

  • +5 more secondary outcomes

Study Arms (2)

Experimental mobilization: Mulligan

EXPERIMENTAL

Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.

Other: Mulligan mobilization

Control mobilization: AP Maitland

ACTIVE COMPARATOR

The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.

Other: AP Maitland mobilization

Interventions

Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.

Experimental mobilization: Mulligan

The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.

Also known as: AP Mobilization
Control mobilization: AP Maitland

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Knee pain diagnosed with osteoarthritis of the knee using the criteria of the American College of Rheumatology
  • Low or no response to pain medication for osteoarthritis knee pain.

You may not qualify if:

  • Suffer from any disorder, syndrome or disease that may cause myofascial or neuropathic pain in the lower limbs, such as lumbar radiculopathy, meralgia paresthetica or saphenous nerve entrapment.
  • Infiltration with steroids or local anaesthetics during the year prior to the patient's participation in the study or during follow-up.
  • History of previous lower extremity or lumbopelvic surgery.
  • Ingestion of substances of abuse that may interfere with treatment.
  • Contraindications to perform joint therapy mobilizations.
  • Previous diagnosis of myopathy or neuropathy (lumbo-sacral plexus)
  • Cognitive deficit manifested in the clinical history (Alzheimer, dementia).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Rey Juan Carlos

Alcorcón, Madrid, 28922, Spain

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Josué Fernández Carnero, Phd

    Universidad Rey Juan Carlos

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It is an experimental, prospective, parallel and longitudinal double-blind study with elderly patients with knee osteoarthritis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Profesor

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 5, 2020

Study Start

April 30, 2020

Primary Completion

May 15, 2020

Study Completion

June 10, 2020

Last Updated

July 27, 2020

Record last verified: 2020-07

Locations